Published Jul 14, 2023
#954 Dexcom COO Jake Leach: G7, G6, Type 2 and your Questions
Dexcom COO Jake Leach shares insights into the advancements of the G7 and G6 models, emphasizing software enhancements, accuracy, and automated insulin delivery systems to improve diabetes management for both Type 1 and Type 2 diabetics. He addresses challenges in the global rollout and provides practical tips for sensor usage, underscoring Dexcom's commitment to innovation and user satisfaction.
Topics covered
Popular Clips
Questions from this episode
Episode Highlights
Related Episodes
#806 Dexcom G7 Approved By FDA (with Dexcom COO Jake Leach)
Answers 383 questions#510 Dexcom G7 App Refresh with Dexcom CTO
Answers 383 questions#184 Jake Leach is Back
Answers 383 questions
#694 Dexcom CEO chats from ADA 2022
Answers 383 questions
#782 Dexcom G7 User
Answers 383 questions#418 Dexcom G7 Update
Answers 383 questions#116 Dexcom Update with CEO Kevin Sayer
Answers 383 questions#158 Dexcom G6 Overview With Dexcom President Kevin Sayer
Answers 383 questions#498 Dexcom G7 Talk With Dexcom CEO Kevin Sayer
Answers 383 questions#239 Dexcom Suggestion Box
Answers 383 questions#676 Dexcom G7 is Getting Close
Answers 383 questions#234 Dexcom CEO Kevin Sayer Returns
Answers 383 questions
#768 Dexcom G7 Design
Answers 383 questions#345 Dexcom CEO Returns
Answers 383 questions#168 Dexcom G6 One Month Review
Answers 383 questions